A Phase 2/3 interventional study of Peer matching and Quailfied Exercise Professional (QEP) Support in Cancer, sponsored by McMaster University. Recruiting at 1 site in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by McMaster University · Phase 2/3, Interventional, and Supportive care
Background:
As Canada's population ages, the number of older adults facing cancer is on the rise. By 2030, 23% of Canadians will be over 65, and two in five will be diagnosed with cancer in their lifetime. This situation is compounded by many older adults experiencing functional decline and social isolation, impacting their quality of life (QOL). While regular exercise can mitigate these effects, older adults with cancer often struggle to meet exercise guidelines, leading to decreased physical and mental well-being.
Objectives:
Our study aims to evaluate the effectiveness of a novel, virtually delivered peer-based exercise intervention designed specifically for older adults with cancer.
Methods:
We will conduct a randomized trial with three groups involving older adults (65 years and older) who have a previous cancer diagnosis. Participants will be divided into three groups: one group will receive peer support along with tailored guidance from qualified exercise professionals (PartnerMatchPLUS), another group will receive peer support only (PartnerMatch), and the third group will receive usual care with no intervention. Over 10 weeks, participants will engage in a structured exercise program supported by peer matching, a peer support guide, educational materials about exercise guidelines, and a Fitbit to track their activity levels. We will assess outcomes at four time points: baseline, post intervention, post tapering, and at a six-month follow-up. Key outcomes include measured and self-reported exercise volume, social support levels, QOL, frailty, and physical activity enjoyment. In addition to these measures, we will conduct one-on-one virtual interviews to explore participants' experiences and the mechanisms that make peer support effective.
Impact:
If successful, this intervention could serve as a scalable model to encourage physical activity, promote social interaction, and ultimately enhance the psychosocial well-being of older adults with cancer.
Background:
By 2030, 23% of Canadians will be over 65 years of age. Two in five of these individuals will be diagnosed with cancer during their lifetime. Older adults have high levels of functional decline and morbidity, and a cancer diagnosis adds prolonged physical sequelae to the natural aging process. Many of these effects can be mitigated by regular exercise. However, older adults with cancer are significantly less likely to meet current exercise guidelines compared to their younger counterparts. Additionally, psychological symptoms from fewer social interactions leads to decreased quality of life (QOL) among older adults with cancer. Our previous work demonstrated that peer-based exercise interventions improve exercise levels and physical outcomes in younger adult populations. However, there is little research on peer-based interventions to promote exercise in older adults and in cancer populations alone, and no literature among older cancer populations. As our population ages, there is a need to develop effective, scalable interventions that support health in older adults with cancer.
Research Aims:
The primary aim of this study is to determine if older adults with cancer who participate in a virtually delivered peer matching exercise intervention with qualified exercise professional (QEP) support have improved exercise volume, social support, QOL, frailty, and physical activity enjoyment compared to those who are matched with a peer only and a usual care group receiving no intervention. We will also examine the cost effectiveness of the intervention over 6-months and the mechanisms of an effective peer match qualitatively.
Methods:
There are two parts to this study. Part 1 is a three-arm randomized controlled trial. Participants will include older adults (over 60 years) living with or beyond a cancer diagnosis (any type or stage of cancer) who are cleared for exercise and have access to an internet-connected device. Participants will be randomized to 3 groups: 1) PartnerMatchPLUS: peer support plus tailored QEP virtual support for 10 weeks, 2) PartnerMatch: peer support only for 10 weeks, or 3) Control: usual care (no intervention). Dyads in both the PartnerMatchPLUS and PartnerMatch groups will be matched with a partner, given a peer support guide, information on current exercise guidelines, and a Fitbit, and be asked to support each other around exercise for 10 weeks. Descriptive statistics will be reported for each group and an analysis of covariance (ANCOVA) will be used to determine between group differences across timepoints. In Part 2, participants will complete a virtual 1-on-1 interview to determine key elements and mechanisms of the peer-based intervention.
Expected Outcomes:
Participants will be assessed at 4 times: baseline, post-intervention (10 weeks post baseline), post-tapering (14 weeks post baseline) and 6-months follow-up (26 weeks post baseline). The primary effectiveness outcome is device measured exercise volume at post-intervention. Secondary effectiveness outcomes include self-report exercise volume, social support, QOL, frailty, physical activity enjoyment, and cost-effectiveness.
Impact:
Our team includes experts in oncology, rehabilitation, social support, aging, and statistics. If effective, this will be the first virtual peer-based exercise intervention for older adult cancer survivors. Project findings will inform future methods aimed to increase exercise in older adults through accessible exercise supports.
10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.
This study's planned enrollment of 183 is above the median of 60 across 7,703 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →McMaster University is the lead sponsor of 741 studies on the registry; 127 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 3 (43%) have results posted.
Counted across the registry records on this site, refreshed daily.
The criteria were revised on the registry on Oct 29, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group will have dyads take part together in weekly virtual sessions with a qualified exercise professional (QEP) for 10 weeks. Sessions will last 1 hour. The QEP will provide tailored exercise counselling for both individuals in the dyad based on personal circumstances, cancer-related characteristics, side effects, and current fitness level with an overall goal of having them meet exercise guidelines for cancer survivors by the intervention end. A standardized guide will be used to deliver weekly sessions, personalized to participants' goals. Content discussed at sessions will include informational support (benefits of exercise), tangible assistance (suggestions for an exercise program), emotional support (overcoming barriers), and esteem support (encouragement). For four weeks following the 10-week intervention, the QEP will be available for consultation to answer questions as needed.
Behavioral: Peer matching · Behavioral: Quailfied Exercise Professional (QEP) Support
Dyads in this group will independently communicate and support each other around exercise for 10 weeks. They will not have contact with the study QEP during the intervention or tapering period. They will be asked to check in with their partner at least once per week but otherwise will structure their communication (mode and frequency) with their matched peer. After the final assessment time point, dyads in this group will be offered a single virtual session with the study QEP to discuss exercise-related questions. They will be asked to document any exercise-related questions that come up during the study period to be answered during the QEP session.
Behavioral: Peer matching
Participants in this group will receive no intervention. They will not be introduced to a partner and will not communicate with the study QEP throughout the project. They will be offered a single session with the study QEP after the final assessment (and asked to track questions).
A Research Coordinator (RC) will match all participants into dyads after consent and baseline data have been completed based on evidence-informed criteria. To be matched participants must be in the same time zone, same sex, and be in the same age range. Beyond these core criteria, we will match based on personal and cancer-related characteristics (i.e., type, stage, treatment status, and exercise preferences). Matched peers in the two intervention groups only (not the control group) will be introduced to each other by the RC on Zoom after randomization. Participants in these two groups will be asked to independently communicate and support their partner around exercise for the duration of the study. They will be given an evidence-based peer support guide (with information on goal setting, communicating with peers, types of support, communication preferences, and study team contact information) an infographic on activity guidelines for older adult cancer survivors, and a Fitbit Inspire.
The QEP will provide tailored exercise counselling for both individuals in the dyad based on personal circumstances, cancer-related characteristics, side effects, and current fitness level with an overall goal of having them meet exercise guidelines for cancer survivors. A standardized guide, used in our pilots, will be used to deliver weekly sessions, personalized to participants' goals. The QEP will have advanced training in exercise for cancer. For four weeks following the 10-week intervention, the QEP will be available for consultation ("tapering" period) to answer questions as needed.
Change in exercise volume
The primary effectiveness outcome is device-measured exercise volume at post-intervention follow-up. A Fitbit Inspire 3© will be used as a device-based measure of exercise volume. Fitbits will be mailed to participants to wear on the non-dominant wrist for 7 consecutive days at each assessment time point to determine average daily and weekly minutes of exercise. The RC will collect data in the online Fitbit database in participant de-identified study accounts. Higher scores represent higher levels of exercise.
Time frame: Post intervention (10-weeks post baseline)
Change in exercise volume
Device-measured exercise volume will also be measured post-tapering (14 weeks post baseline). A Fitbit Inspire 3© will be used as a device-based measure of exercise volume. Fitbits will be mailed to participants to wear on the non-dominant wrist for 7 consecutive days at each assessment time point to determine average daily and weekly minutes of exercise. The RC will collect data in the online Fitbit database in participant de-identified study accounts. Higher scores represent higher levels of exercise.
Time frame: Post-tapering (14 weeks post baseline)
Change in exercise volume
Device-measured exercise volume will also be measured at 6 month follow up. A Fitbit Inspire 3© will be used as a device-based measure of exercise volume. Fitbits will be mailed to participants to wear on the non-dominant wrist for 7 consecutive days at each assessment time point to determine average daily and weekly minutes of exercise. The RC will collect data in the online Fitbit database in participant de-identified study accounts. Higher scores represent higher levels of exercise.
Time frame: 6 months follow-up (26 weeks post-baseline)
Change in level of perceived social support
An exercise-specific version of the social support survey (SSS) will assess social support. The SSS is validated in cancer survivors56 and has high construct validity. Within this survey seven dimensions of social support are assessed (listening support, emotional support, esteem support, reality confirmation, task challenge, tangible assistance, informational support). Respondents report on the number of support providers and satisfaction with each type of support on a five-point Likert scale. Higher scores represent higher levels of perceived social support.
Time frame: Post-intervention (10 weeks post baseline)
Change in level of perceived social support
An exercise-specific version of the social support survey (SSS) will assess social support. The SSS is validated in cancer survivors56 and has high construct validity. Within this survey seven dimensions of social support are assessed (listening support, emotional support, esteem support, reality confirmation, task challenge, tangible assistance, informational support). Respondents report on the number of support providers and satisfaction with each type of support on a five-point Likert scale. Higher scores represent higher levels of perceived social support.
Time frame: Post-tapering (14 weeks post baseline)
Change in level of perceived social support
An exercise-specific version of the social support survey (SSS) will assess social support. The SSS is validated in cancer survivors56 and has high construct validity. Within this survey seven dimensions of social support are assessed (listening support, emotional support, esteem support, reality confirmation, task challenge, tangible assistance, informational support). Respondents report on the number of support providers and satisfaction with each type of support on a five-point Likert scale. Higher scores represent higher levels of perceived social support.
Time frame: 6 month follow up (26 weeks post baseline)
Change in frailty levels
The Geriatric 8 Questionnaire (G8) will assess participant frailty levels. The G8 consists of 8 items: food intake, weight loss, mobility, psychological status, body mass index, medication number, and self-perception of health. The 8 items provide a total score ranging from 0 (frailty) to 17 (no impairment). A score of ≤14 indicates frailty. The G8 has been validated in cancer survivors. Higher scores represent lower levels of frailty.
Time frame: Post-intervention (10 weeks post baseline)
Change in frailty levels
The Geriatric 8 Questionnaire (G8) will assess participant frailty levels. The G8 consists of 8 items: food intake, weight loss, mobility, psychological status, body mass index, medication number, and self-perception of health. The 8 items provide a total score ranging from 0 (frailty) to 17 (no impairment). A score of ≤14 indicates frailty. The G8 has been validated in cancer survivors. Higher scores represent lower levels of frailty.
Time frame: Post-tapering (14 weeks post baseline)
Change in frailty levels
The Geriatric 8 Questionnaire (G8) will assess participant frailty levels. The G8 consists of 8 items: food intake, weight loss, mobility, psychological status, body mass index, medication number, and self-perception of health. The 8 items provide a total score ranging from 0 (frailty) to 17 (no impairment). A score of ≤14 indicates frailty. The G8 has been validated in cancer survivors. Higher scores represent lower levels of frailty.
Time frame: 6 months follow up (26 weeks post baseline)
Change in quality of life (QOL)
The SF-12 will be used to measure QOL. The SF-12 is a self-administered questionnaire including 12 items addressing eight health domains (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). Higher scores represent higher levels of QOL.
Time frame: Post-intervention (10 weeks post baseline)
Change in quality of life (QOL)
The SF-12 will be used to measure QOL. The SF-12 is a self-administered questionnaire including 12 items addressing eight health domains (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). Higher scores represent higher levels of QOL.
Time frame: Post-tapering (14 weeks post baseline)
Change in quality of life (QOL)
The SF-12 will be used to measure QOL. The SF-12 is a self-administered questionnaire including 12 items addressing eight health domains (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). Higher scores represent higher levels of QOL.
Time frame: 6 month follow up (26 weeks post baseline)
Change in quality of life (QOL)
The EQ-5D-3L will be used to measure QOL. The EQ-5D-3L includes a 3-level scale assessing five dimensions of health (mobility, self-care, activities, pain, and anxiety/depression), and a visual analogue scale where users rate their perception of current health on a scale of 0-10 (worst to best imaginable health). It is reliable and valid for individuals with cancer. Higher scores represent higher levels of QOL.
Time frame: Post-intervention (10 weeks post baseline)
Change in quality of life (QOL)
The EQ-5D-3L will be used to measure QOL. The EQ-5D-3L includes a 3-level scale assessing five dimensions of health (mobility, self-care, activities, pain, and anxiety/depression), and a visual analogue scale where users rate their perception of current health on a scale of 0-10 (worst to best imaginable health). It is reliable and valid for individuals with cancer. Higher scores represent higher levels of QOL.
Time frame: Post-tapering (14 weeks post baseline)
Change in quality of life (QOL)
The EQ-5D-3L will be used to measure QOL. The EQ-5D-3L includes a 3-level scale assessing five dimensions of health (mobility, self-care, activities, pain, and anxiety/depression), and a visual analogue scale where users rate their perception of current health on a scale of 0-10 (worst to best imaginable health). It is reliable and valid for individuals with cancer. Higher scores represent higher levels of QOL.
Time frame: 6 months follow up (26 weeks post baseline)
Change in physical activity enjoyment
Physical activity enjoyment will be measured using the Physical Activity Enjoyment Scale (PACES). This 18-item scale assesses enjoyment of the physical activity respondents are doing on a 7-point Likert scale from 1 (I hate it) to 7 (I enjoy it). Higher scores represent greater enjoyment. The scale is valid and reliable in adults with functional limitations.
Time frame: Post-intervention (10 weeks post baseline)
Change in physical activity enjoyment
Physical activity enjoyment will be measured using the Physical Activity Enjoyment Scale (PACES). This 18-item scale assesses enjoyment of the physical activity respondents are doing on a 7-point Likert scale from 1 (I hate it) to 7 (I enjoy it). Higher scores represent greater enjoyment. The scale is valid and reliable in adults with functional limitations.
Time frame: Post-tapering (14 weeks post baseline)
Change in physical activity enjoyment
Physical activity enjoyment will be measured using the Physical Activity Enjoyment Scale (PACES). This 18-item scale assesses enjoyment of the physical activity respondents are doing on a 7-point Likert scale from 1 (I hate it) to 7 (I enjoy it). Higher scores represent greater enjoyment. The scale is valid and reliable in adults with functional limitations.
Time frame: 6 months follow up (26 weeks post baseline)
Change in exercise volume
Self-report exercise volume will be measured post-intervention (10 weeks post baseline). The Godin Leisure Time Exercise Questionnaire will be used as the self-report measure of exercise volume. Higher scores represent higher levels of exercise. The scale is valid and reliable in adults
Time frame: Post-baseline (10 weeks post baseline)
Change in exercise volume
Self-report exercise volume will also be measured post-tapering (14 weeks post baseline). The Godin Leisure Time Exercise Questionnaire will be used as the self-report measure of exercise volume. Higher scores represent higher levels of exercise. The scale is valid and reliable in adults
Time frame: Post-tapering (14 weeks post baseline)
Change in exercise volume
Self-report exercise volume will also be measured at 6-month follow-up (26 weeks post baseline). The Godin Leisure Time Exercise Questionnaire will be used as the self-report measure of exercise volume. Higher scores represent higher levels of exercise. The scale is valid and reliable in adults
Time frame: 6-month follow-up (26 weeks post baseline)
Difference in use of health care services
Use of health care services will be assessed using a piloted self-report form at post-intervention. The survey assesses the number of healthcare visits, family physician appointments, procedures received, support services accessed, and days of lost work. Survey results will be used to compare healthcare resource utilization between the three study groups. Higher scores represent high levels of service use.
Time frame: Post-intervention (10 weeks pos baseline)
Difference in use of health care services
Use of health care services will be assessed using a piloted self-report form at post-tapering. The survey assesses the number of healthcare visits, family physician appointments, procedures received, support services accessed, and days of lost work. Survey results will be used to compare healthcare resource utilization between the three study groups. Higher scores represent high levels of service use.
Time frame: Post-tapering (14 weeks pos baseline)
Difference in use of health care services
Use of health care services will be assessed using a piloted self-report form at 6-month follow-up. The survey assesses the number of healthcare visits, family physician appointments, procedures received, support services accessed, and days of lost work. Survey results will be used to compare healthcare resource utilization between the three study groups. Higher scores represent high levels of service use.
Time frame: 6-month follow-up (26 weeks pos baseline)
Plan to share: Undecided
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for May 2028, 20 months after the start.
Of 47 phase 2/3 interventional studies under Neoplasms, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 90. This study's planned 20 months is below that.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.